Use of flash glucose monitoring is associated with HbA1c reduction in type 2 diabetes managed with basal insulin in Canada: A real-world prospective observational study

This publication has 15 references indexed in Scilit:

• Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking
  Diabetes Technology & Therapeutics, 2023
• The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
  The Lancet Diabetes & Endocrinology, 2022
• The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study
  Diabetes Research and Clinical Practice, 2022
• IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
  Diabetes Research and Clinical Practice, 2022
• 7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
  Diabetes Care, 2021
• The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
  Diabetes Care, 2021
• Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin
  JAMA, 2021
• Use of Flash Continuous Glucose Monitoring Is Associated With A1C Reduction in People With Type 2 Diabetes Treated With Basal Insulin or Noninsulin Therapy
  Diabetes Spectrum, 2021
• Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial
  Diabetes Therapy, 2016
• Note on the Sampling Error of the Difference Between Correlated Proportions or Percentages
  Psychometrika, 1947